AJJ Medtech Holdings Limited (SGX:584)

Market Cap	8.56M +42.3%
Revenue (ttm)	3.19M +37.4%
Net Income	-2.93M
EPS	-0.00
Shares Out	1.71B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,340,800
Average Volume	6,070,610
Open	0.0060
Previous Close	0.0060
Day's Range	0.0050 - 0.0060
52-Week Range	0.0020 - 0.0120
Beta	0.61
RSI	39.16
Earnings Date	May 15, 2026

About AJJ Medtech Holdings

AJJ Medtech Holdings Limited, an investment holding company, provides integrated medical technology solutions for healthcare sector in Singapore. It develops, integrates, and sells complementary digital, artificial intelligence (AI), and robotics solutions. The company also offers Samsung Medison ultrasound medical devices and solutions for general imaging, women's health, and point-of-care applications; in-vitro diagnostics and life sciences, including point-of-care diagnostics equipment, such as blood glucose monitoring system and single-use ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 39
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 584

Financial Performance

In 2025, AJJ Medtech Holdings's revenue was 3.19 million, an increase of 37.41% compared to the previous year's 2.32 million. Losses were -2.93 million, -24.17% less than in 2024.